Ignite Creation Date:
2024-05-06 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05829356
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2023-04-06
Brief Title:
Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP in Adult Participants Aged 18 to 49 Years and 60 Years and Above
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
VAV00019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi Pasteur a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None